Cargando…

Impact of Ovarian Metastatectomy on Survival Outcome of Colorectal Cancer Patients with Ovarian Metastasis: A Retrospective Study

BACKGROUND: Ovarian metastasis from colorectal cancer (CRC) is rare and lacks standard treatment. The benefit of metastatectomy remains to be elucidated. This study was conducted to assess the impact of metastatectomy on survival outcome and explore prognostic factors in ovarian metastatic CRC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaofen, Huang, Hai, Ran, Longyao, Fang, Chao, Yu, Yongyang, Luo, Manxi, Qiu, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297340/
https://www.ncbi.nlm.nih.gov/pubmed/32606943
http://dx.doi.org/10.2147/CMAR.S254876
_version_ 1783546983691059200
author Li, Xiaofen
Huang, Hai
Ran, Longyao
Fang, Chao
Yu, Yongyang
Luo, Manxi
Qiu, Meng
author_facet Li, Xiaofen
Huang, Hai
Ran, Longyao
Fang, Chao
Yu, Yongyang
Luo, Manxi
Qiu, Meng
author_sort Li, Xiaofen
collection PubMed
description BACKGROUND: Ovarian metastasis from colorectal cancer (CRC) is rare and lacks standard treatment. The benefit of metastatectomy remains to be elucidated. This study was conducted to assess the impact of metastatectomy on survival outcome and explore prognostic factors in ovarian metastatic CRC patients. METHODS: Information of ovarian metastatic CRC patients between January 2008 and December 2017 were collected retrospectively from database of West China Hospital, Sichuan University. Kaplan–Meier method was used to estimate disease-specific survival (DSS) after diagnosis of ovarian metastasis, and multivariate Cox regression analysis was applied to identify prognostic factors. RESULTS: Totally, 68 female patients from a cohort of 2170 cases were eligible. The median age at diagnosis was 46.5 years. The median DSS was 25.0 months (95% confidence interval (CI): 21.0–29.0 months). Kaplan–Meier analysis and Log rank test showed that complete resection of ovarian metastases (median DSS: 33.0 months) could significantly prolong patients’ survival time, compared with palliative and no resection (median DSS: 20.0 months and 22.0 months, respectively), regardless of systemic chemotherapy (P<0.05). Multivariate analysis demonstrated regional lymph nodes metastasis of primary tumor (hazard ratio (HR): 3.438, 95% CI: 1.094–10.810, P=0.035), primary tumor resection (HR: 6.436, 95% CI: 1.770–23.399, P=0.005), differentiation grade (HR: 0.272, 95% CI: 0.107–0.693, P=0.006), complete resection of ovarian metastases (vs palliative resection: HR: 17.091, 95% CI: 3.040–96.099, P=0.001; vs no resection: HR: 9.519, 95% CI: 1.581–57.320, P=0.014), and systemic chemotherapy (HR: 3.059, 95% CI: 1.089–8.595 P=0.034) were independent prognostic factors. CONCLUSION: Complete resection of ovarian metastases could independently predict favorable survival in ovarian metastatic CRC, while palliative resection could not improve patients’ prognosis compared with no resection.
format Online
Article
Text
id pubmed-7297340
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72973402020-06-29 Impact of Ovarian Metastatectomy on Survival Outcome of Colorectal Cancer Patients with Ovarian Metastasis: A Retrospective Study Li, Xiaofen Huang, Hai Ran, Longyao Fang, Chao Yu, Yongyang Luo, Manxi Qiu, Meng Cancer Manag Res Original Research BACKGROUND: Ovarian metastasis from colorectal cancer (CRC) is rare and lacks standard treatment. The benefit of metastatectomy remains to be elucidated. This study was conducted to assess the impact of metastatectomy on survival outcome and explore prognostic factors in ovarian metastatic CRC patients. METHODS: Information of ovarian metastatic CRC patients between January 2008 and December 2017 were collected retrospectively from database of West China Hospital, Sichuan University. Kaplan–Meier method was used to estimate disease-specific survival (DSS) after diagnosis of ovarian metastasis, and multivariate Cox regression analysis was applied to identify prognostic factors. RESULTS: Totally, 68 female patients from a cohort of 2170 cases were eligible. The median age at diagnosis was 46.5 years. The median DSS was 25.0 months (95% confidence interval (CI): 21.0–29.0 months). Kaplan–Meier analysis and Log rank test showed that complete resection of ovarian metastases (median DSS: 33.0 months) could significantly prolong patients’ survival time, compared with palliative and no resection (median DSS: 20.0 months and 22.0 months, respectively), regardless of systemic chemotherapy (P<0.05). Multivariate analysis demonstrated regional lymph nodes metastasis of primary tumor (hazard ratio (HR): 3.438, 95% CI: 1.094–10.810, P=0.035), primary tumor resection (HR: 6.436, 95% CI: 1.770–23.399, P=0.005), differentiation grade (HR: 0.272, 95% CI: 0.107–0.693, P=0.006), complete resection of ovarian metastases (vs palliative resection: HR: 17.091, 95% CI: 3.040–96.099, P=0.001; vs no resection: HR: 9.519, 95% CI: 1.581–57.320, P=0.014), and systemic chemotherapy (HR: 3.059, 95% CI: 1.089–8.595 P=0.034) were independent prognostic factors. CONCLUSION: Complete resection of ovarian metastases could independently predict favorable survival in ovarian metastatic CRC, while palliative resection could not improve patients’ prognosis compared with no resection. Dove 2020-06-12 /pmc/articles/PMC7297340/ /pubmed/32606943 http://dx.doi.org/10.2147/CMAR.S254876 Text en © 2020 Li et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Xiaofen
Huang, Hai
Ran, Longyao
Fang, Chao
Yu, Yongyang
Luo, Manxi
Qiu, Meng
Impact of Ovarian Metastatectomy on Survival Outcome of Colorectal Cancer Patients with Ovarian Metastasis: A Retrospective Study
title Impact of Ovarian Metastatectomy on Survival Outcome of Colorectal Cancer Patients with Ovarian Metastasis: A Retrospective Study
title_full Impact of Ovarian Metastatectomy on Survival Outcome of Colorectal Cancer Patients with Ovarian Metastasis: A Retrospective Study
title_fullStr Impact of Ovarian Metastatectomy on Survival Outcome of Colorectal Cancer Patients with Ovarian Metastasis: A Retrospective Study
title_full_unstemmed Impact of Ovarian Metastatectomy on Survival Outcome of Colorectal Cancer Patients with Ovarian Metastasis: A Retrospective Study
title_short Impact of Ovarian Metastatectomy on Survival Outcome of Colorectal Cancer Patients with Ovarian Metastasis: A Retrospective Study
title_sort impact of ovarian metastatectomy on survival outcome of colorectal cancer patients with ovarian metastasis: a retrospective study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297340/
https://www.ncbi.nlm.nih.gov/pubmed/32606943
http://dx.doi.org/10.2147/CMAR.S254876
work_keys_str_mv AT lixiaofen impactofovarianmetastatectomyonsurvivaloutcomeofcolorectalcancerpatientswithovarianmetastasisaretrospectivestudy
AT huanghai impactofovarianmetastatectomyonsurvivaloutcomeofcolorectalcancerpatientswithovarianmetastasisaretrospectivestudy
AT ranlongyao impactofovarianmetastatectomyonsurvivaloutcomeofcolorectalcancerpatientswithovarianmetastasisaretrospectivestudy
AT fangchao impactofovarianmetastatectomyonsurvivaloutcomeofcolorectalcancerpatientswithovarianmetastasisaretrospectivestudy
AT yuyongyang impactofovarianmetastatectomyonsurvivaloutcomeofcolorectalcancerpatientswithovarianmetastasisaretrospectivestudy
AT luomanxi impactofovarianmetastatectomyonsurvivaloutcomeofcolorectalcancerpatientswithovarianmetastasisaretrospectivestudy
AT qiumeng impactofovarianmetastatectomyonsurvivaloutcomeofcolorectalcancerpatientswithovarianmetastasisaretrospectivestudy